Legal & General Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,094
Closed -$9K 3798
2021
Q1
$9K Sell
2,094
-28,260
-93% -$156K ﹤0.01% 3422
2020
Q4
$118K Buy
30,354
+28,260
+1,350% +$121K ﹤0.01% 2540
2020
Q3
$8K Sell
2,094
-1,110
-35% -$4.6K ﹤0.01% 3334
2020
Q2
$14K Hold
3,204
﹤0.01% 3230
2020
Q1
$13K Sell
3,204
-776
-19% -$4.9K ﹤0.01% 3106
2019
Q4
$16K Buy
3,980
+784
+25% +$4.63K ﹤0.01% 3237
2019
Q3
$28K Hold
3,196
﹤0.01% 3012
2019
Q2
$30K Sell
3,196
-381
-11% -$2.87K ﹤0.01% 3038
2019
Q1
$23K Hold
3,577
﹤0.01% 3059
2018
Q4
$34K Hold
3,577
﹤0.01% 2860
2018
Q3
$72K Hold
3,577
﹤0.01% 2610
2018
Q2
$104K Buy
3,577
+547
+18% +$16.9K ﹤0.01% 2492
2018
Q1
$90K Sell
3,030
-1,399
-32% -$45.1K ﹤0.01% 2507
2017
Q4
$143K Hold
4,429
﹤0.01% 2439
2017
Q3
$153K Sell
4,429
-27
-0.6% -$868 ﹤0.01% 2438
2017
Q2
$133K Buy
4,456
+462
+12% +$13.2K ﹤0.01% 2461
2017
Q1
$121K Hold
3,994
﹤0.01% 2447
2016
Q4
$68K Buy
3,994
+1,953
+96% +$37.4K ﹤0.01% 2778
2016
Q3
$48K Hold
2,041
﹤0.01% 2544
2016
Q2
$33K Hold
2,041
﹤0.01% 2692
2016
Q1
$41K Hold
2,041
﹤0.01% 2501
2015
Q4
$56K Buy
+2,041
New +$55.7K ﹤0.01% 2408

Other funds holding LJPC

Legal & General Group's LJPC Position: Q2 2021 in Review

Legal & General Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 2,094 shares — an estimated $9K sold.

Legal & General Group first reported a position in LJPC in Q4 2015 and held it in 22 quarters. The position peaked at $153K in Q3 2017. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Legal & General Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 2,094 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $9K.
  • Legal & General Group first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 22 quarters.
  • Legal & General Group's La Jolla Pharmaceutical Company position peaked at $153K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.